PTM Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
PTM Therapeutics General Information
Description
Developer of a post-translational modification technology designed for disease-specific targets on therapeutic antibodies. The company's technology is used to distinguish healthy cells or tissues from diseased cells or tissues and is important in various biological dysfunctions, enabling pharmaceutical developers to discover targets and develop new therapeutics for the treatment of chronic diseases and cancer.
Contact Information
Website
www.ptmthera.comCorporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Corporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
PTM Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 1. Early Stage VC | 01-Jan-2020 | Completed | Pre-Clinical Trials |
PTM Therapeutics Patents
PTM Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260174847-A1 | Methods of treating digestive diseases and compositions thereof | Pending | 21-Aug-2023 | ||
| WO-2025042888-A1 | Methods of treating digestive diseases and compositions thereof | Inactive | 21-Aug-2023 | ||
| AU-2023204801-A1 | Methods of treating solid tumors and compositions thereof | Pending | 06-Jan-2022 | ||
| EP-4460331-A1 | Methods of treating solid tumors and compositions thereof | Pending | 06-Jan-2022 | ||
| US-20250064966-A1 | Methods of treating solid tumors and compositions thereof | Pending | 06-Jan-2022 | A61K47/6851 |
PTM Therapeutics Signals
PTM Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Springboard Enterprises | Accelerator/Incubator | Minority | ||
| Biobrit | Venture Capital | Minority | ||
| BioRock Ventures | Venture Capital | Minority | ||
| Innovation Partnerships | Venture Capital | Minority |
PTM Therapeutics FAQs
-
When was PTM Therapeutics founded?
PTM Therapeutics was founded in 2019.
-
Where is PTM Therapeutics headquartered?
PTM Therapeutics is headquartered in San Carlos, CA.
-
What is the size of PTM Therapeutics?
PTM Therapeutics has 2 total employees.
-
What industry is PTM Therapeutics in?
PTM Therapeutics’s primary industry is Drug Discovery.
-
Is PTM Therapeutics a private or public company?
PTM Therapeutics is a Private company.
-
What is PTM Therapeutics’s current revenue?
The current revenue for PTM Therapeutics is .
-
Who are PTM Therapeutics’s investors?
Springboard Enterprises, Biobrit, BioRock Ventures, and Innovation Partnerships have invested in PTM Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process